Report of Independent Registered Public Accounting Firm

To the Board of Trustees of
Templeton Institutional Funds and
Shareholders of Foreign Smaller Companies Series,
Global Equity Series and International Equity Series

In planning and performing our audit of the financial statements of
Foreign Smaller Companies Series, Global Equity Series
and International Equity Series (the "Funds") as of and for the year
ended December 31, 2018, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) ("PCAOB"),
we considered the Funds' internal control over financial reporting,
including controls over safeguarding securities, as a basis for
designing our auditing procedures for the purpose of expressing
our opinion on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of expressing
an opinion on the effectiveness of the Funds' internal control over
financial reporting.  Accordingly, we do not express an opinion on the
effectiveness of the Funds' internal control over financial reporting.

The management of the Funds is responsible for establishing and
maintaining effective internal control over financial reporting.
In fulfilling this responsibility, estimates and judgments by
management are required to assess the expected benefits and related
costs of controls.  A company's internal control over financial
reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with
generally accepted accounting principles.  A company's internal
control over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of records that,
in reasonable detail, accurately and fairly reflect the transactions
and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that
receipts and expenditures of the company are being made only in
accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of
a company's assets that could have a material
effect on the financial statements.

Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements.  Also, projections
of any evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or
procedures may deteriorate.

A deficiency in internal control over financial reporting exists when
the design or operation of a control does not allow management or
employees, in the normal course of performing their assigned functions,
to prevent or detect misstatements on a timely basis.  A material
weakness is a deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a reasonable
possibility that a material misstatement of the company's annual
or interim financial statements will not be prevented or detected
on a timely basis.

Our consideration of the Funds' internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
internal control over financial reporting that might be material
weaknesses under standards established by the PCAOB.  However, we noted
the following deficiency in the Funds' internal control over financial
reporting and its operation, including controls over safeguarding
securities, that we consider to be a material weakness as
defined above as of December 31, 2018.

Management and PwC identified that at December 31, 2018 management's
controls were ineffective related to internal control over
financial reporting specific to the monitoring of market events
following the close of trading in foreign stock markets that
assist in determining the reliability of the values of the
foreign securities held by the Funds and which may require the
use of fair valuation factors to account for changes in the values
of those securities subsequent to the local close of the foreign market
but prior to the net asset calculation of the Funds. This material
weakness did not result in misstatements in the Funds' interim
or annual financial statements.  However, this material weakness could
result in misstatements of security values and unrealized gains or
losses and associated disclosures that would result in a material
misstatement of the financial statements that would not be prevented
or detected. As a result, a material weakness exists at
 December 31, 2018 for the Funds.
Effective November 1, 2018 the Registrant's controls were further
enhanced through the implementation of a daily secondary review of
market events following the close of trading on foreign stock markets
to ensure the appropriate application of market level fair value.
We have not performed any procedures to assess this corrective action,
including its sufficiency in addressing the material
weakness described above.

This report is intended solely for the information and use of the
Board of Trustees of Templeton Institutional Funds
and the Securities and Exchange Commission and is not intended
to be and should not be used by anyone other than these specified parties.



/s/PricewaterhouseCoopers LLP
San Francisco, California
February 15, 2019